A Houston-based company is taking a medicine-free approach to target brain neurologically associated with mental illness.
Nexalin Technology’s patented, FDA-cleared frequency-based waveform targets key centers of the midbrain to support the...
Editor's note: It's time to recap the top innovation news for the first half of May 2025. Our five most-read stories from May 1-15 include updates from Intuitive Machines and The Ion. Plus, driverless trucks hit the road from Houston to Dal...
We use cookies to keep you signed in, remember your preferences and measure how the site is used. By continuing to browse Parsers VC you agree to that. Privacy & Terms
How would you rate Parsers VC?
On a scale from 1 to 10, how would you rate Parsers VC overall? It takes one click and helps us decide what to improve.
1 – poor10 – excellent
Thank you!
Your rating helps us make Parsers VC better.
Your rating was not saved
Something went wrong on our side. We will ask you again on one of your next visits.
Enjoying Parsers VC?
Thank you for rating Parsers VC so highly. Would you share your experience on G2? A short review helps other investors and founders find us.